Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹6,376 Cr₹5,967 Cr₹5,819 Cr₹4,546 Cr₹4,689 Cr

What is the latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹6,376 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹6,376 Cr
Mar2025₹5,967 Cr
Mar2024₹5,819 Cr
Mar2023₹4,546 Cr
Mar2022₹4,689 Cr

How is Total Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2026 ₹6,376 Cr
6.86
Mar2025 ₹5,967 Cr
2.55
Mar2024 ₹5,819 Cr
27.99
Mar2023 ₹4,546 Cr
-3.05
Mar2022 ₹4,689 Cr -

Compare Total Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹70,263.6 Cr 4% 11.5% 28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹469,310.0 Cr 2% -1.7% 15.9% Stock Analytics
DIVIS LABORATORIES ₹245,426.0 Cr 6.5% 14.8% 48.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,347.0 Cr 1.2% -2.5% 37.2% Stock Analytics
CIPLA ₹114,393.0 Cr -0.3% -3.9% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,240.2 Cr -2.2% 1.5% -8.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4%

11.5%

28.7%

SENSEX

-0.5%

-1.3%

-5.4%


You may also like the below Video Courses